Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Wake Forest University Health Sciences
The Netherlands Cancer Institute
Eikon Therapeutics
Incyte Corporation
Centre Francois Baclesse
BeiGene
Dana-Farber Cancer Institute
Actuate Therapeutics Inc.
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Icahn School of Medicine at Mount Sinai
Canadian Cancer Trials Group
OncoSec Medical Incorporated
The Netherlands Cancer Institute
Fudan University
Shanghai Jiao Tong University School of Medicine
G1 Therapeutics, Inc.
Actuate Therapeutics Inc.
Mereo BioPharma
UNC Lineberger Comprehensive Cancer Center
Gustave Roussy, Cancer Campus, Grand Paris
Eli Lilly and Company
M.D. Anderson Cancer Center
US Oncology Research
Pierre Fabre Medicament
Royal Marsden NHS Foundation Trust
AbbVie
NYU Langone Health
Sanofi
City of Hope Medical Center
Amgen
Ludwig-Maximilians - University of Munich
Eli Lilly and Company